Mentice AB 

€1.19
2
+€0.01+0.85% Thursday 07:08

Statistics

Day High
1.19
Day Low
1.19
52W High
2.05
52W Low
0.81
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-1.06
-0.56
-0.05
0.45
Expected EPS
-0.1894642532
Actual EPS
N/A

Financials

1.31%Profit Margin
Profitable
2012
2013
2014
2015
404.03MRevenue
5.31MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MN2.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical produces robotic surgical systems, competing in the high-tech medical device market similar to Mentice's simulation technology.
Medtronic
MDT
Mkt Cap116.33B
Medtronic offers medical technologies, services, and solutions, including surgical simulation, directly competing with Mentice's offerings.
Smith & Nephew
SNN
Mkt Cap15.61B
Smith & Nephew specializes in surgical devices and advanced wound management, which overlaps with Mentice's surgical training technologies.
Stryker
SYK
Mkt Cap136.19B
Stryker manufactures medical and surgical equipment, including simulation and training tools, competing in the same space as Mentice.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet specializes in musculoskeletal healthcare, including surgical solutions that compete with Mentice's simulation products.
Globus Medical
GMED
Mkt Cap8.16B
Globus Medical develops musculoskeletal solutions, including surgical simulators, which are in direct competition with Mentice's products.
Resmed
RMD
Mkt Cap36.04B
ResMed specializes in cloud-connected medical devices for sleep apnea, COPD, and other chronic diseases, indirectly competing in the broader medical tech field.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific produces medical devices used in various interventions, including endoscopy and urology, competing with Mentice's interventional simulation tech.
ICU Medical
ICUI
Mkt Cap3.03B
ICU Medical provides infusion therapy and related services, competing indirectly by offering high-tech solutions in patient care and training.

About

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations, such as the VIST virtual patient and Laerdal SimMan vascular medical simulator. It also provides flow model products, which include physiological flow systems, silicone and 3D printed vessels, and flow system accessories; Ankyras, a clinical decision application; Mentice Live, a cloud-based learning center for medical technology industry and healthcare providers; Mentice Right Heart Cath app, a mobile solution for interactive real-time exploration into the right heart catheterization procedure; Vascular Twin, an anatomical replication for procedural and device adoption; research and development services; and professional support services for installation, training, and warranty services. It operates in Europe, the Middle East, Africa, the Asia Pacific, and the Americas. Mentice AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden.
Show more...
CEO
Mr. Frans Matthieu Venker
Employees
124
Country
DE
ISIN
SE0012673291
WKN
000A2PK7M

Listings

0 Comments

Share your thoughts

FAQ

What is Mentice AB stock price today?
The current price of MN2.F is €1.19 EUR — it has increased by +0.85% in the past 24 hours. Watch Mentice AB stock price performance more closely on the chart.
What is Mentice AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Mentice AB stocks are traded under the ticker MN2.F.
Is Mentice AB stock price growing?
MN2.F stock has fallen by -4.03% compared to the previous week, the month change is a -12.18% fall, over the last year Mentice AB has showed a -34.25% decrease.
When is the next Mentice AB earnings date?
Mentice AB is going to release the next earnings report on May 07, 2026.
What were Mentice AB earnings last quarter?
MN2.F earnings for the last quarter are 0.04 EUR per share, whereas the estimation was 0.01 EUR resulting in a +691.59% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Mentice AB revenue for the last year?
Mentice AB revenue for the last year amounts to 404.03M EUR.
What is Mentice AB net income for the last year?
MN2.F net income for the last year is 5.31M EUR.
How many employees does Mentice AB have?
As of April 04, 2026, the company has 124 employees.
When did Mentice AB complete a stock split?
Mentice AB has not had any recent stock splits.
Where is Mentice AB headquartered?
Mentice AB is headquartered in Gothenburg, DE.